WASHINGTON –
The Air Force and other military services will expand their drug testing to include testing for commonly abused prescription drugs beginning May 1.
On Jan. 31, the Secretary of Defense gave a 90-day advance notice of the drug testing expansion that aims to counter the nation's growing epidemic and encourage those abusing prescription medications to seek treatment before official testing begins.
"Abuse of prescription drugs is the fastest-growing drug problem in the United States and, unfortunately, this trend is reflected in the military services," Maj. Gen. Thomas W. Travis, deputy Air Force surgeon general, said. "While pain medications are highly effective in alleviating suffering from injuries, they are dangerous and potentially addictive when used outside medical supervision."
Taking controlled medications in a manner other than how they were prescribed poses a risk to the person's health and safety and can put others at risk as well.
Prescription medications should be taken only for the purposes for which they were prescribed and at the dose and frequency prescribed. Additionally, Airmen are reminded never to take a medication prescribed to someone else.
"Members who need help discontinuing use of these drugs are encouraged to seek care at a military treatment facility immediately," Travis said.
The policy being addressed is not new to Air Force personnel. In accordance with Air Force guidance and existing law, the knowing use of any prescription or over-the-counter medications in a manner contrary to their intended medical purpose or in excess of the prescribed dosage may have negative health consequences and may also violate the Uniform Code of Military Justice.
AFI 44-121, Alcohol and Drug Abuse Prevention and Treatment Program provides limited protections under certain circumstances for voluntary disclosure of prior drug use or possession to unit commanders, first sergeants, a substance abuse evaluator or a military medical professional. Once an Airman has been ordered to provide a urine sample as part of the drug testing program, any disclosure is not considered to be voluntary.
"There are no changes to procedures that will directly affect drug testing collection sites and military members who are selected for testing," Lt. Col. Mark Oordt, ADAPT and Drug Demand Reduction chief, said. "The changes will occur at the Drug Testing Labs where the standard panel of substances each specimen is tested for will be expanded."